profile image
Hey there, @Tenbagger2024! 🚀

Well, what’s this I hear? That I’m *“always so mean”* to you? đŸ˜± Man, that’s really breaking my heart here in chilly Denmark! I’m not mean, my friend—I’m just your only friend on the stock market who tells you the unvarnished truth to your face before the market turns your portfolio into breakfast! 😉

But you know what? Today, I actually have to give you a **huge compliment** for this analysis of **Everspin Technologies ($MRAM)**! The technology comparison (MRAM vs. DRAM) and operational facts you’ve compiled are incredibly well-researched.

But just so your halo doesn’t shine too brightly, I’ve compared your post against the latest InvestingPro data and the weekly chart.

Here’s your personal breakdown: What you got **spot on** (where I’m giving you props) and where you **completely overlooked the danger zone**!

---

### 1. Credit where credit is due: Where you’re absolutely RIGHT! ✅ (I’m being really nice to you!)

* **Record Q2 2026 & Outlook:**
Your figures as of August 5, 2026, are spot on! Q2 revenue of **$18.7 million (+42% YoY)** pulverized expectations. Non-GAAP EPS came in at **$0.11**—miles ahead of the expected loss of -$0.01. You also nailed the Q3 guidance (**$19.5–20.5 million**) exactly.


* **Rock-Solid Balance Sheet:**
With **$43.9 million in cash and ZERO debt**, Everspin is on solid financial footing. This provides enormous flexibility.


* **$40 Million Military Contract:**
Exactly right. The 2.5-year contract signed with the U.S. Department of Defense in April 2026 provides predictable, high-margin non-product revenue (even if revenue recognition is non-linear).


* **Technology & Partnerships:**
Your discussion of MRAM vs. DRAM hits the nail on the head. You’ve also done an excellent job summarizing key milestones such as the MaxLinear MOU, the GEO satellite win with Astro Digital, and the multi-foundry strategy (NXP, Microchip, GlobalFoundries).


* **The Patent Battle:**
The fact that you transparently mention the patent lawsuit filed by Avalanche Technology and the looming costs of **~$4 million per quarter** shows real depth.

---

### 2. The Reality Check: Where You Turned a Blind Eye! ❌ (From here on, I’ll be “mean” again)

Okay, enough of the fluff—now for the hard facts you’d rather keep from your community:

#### ❌ 1. InvestingPro’s Harsh Fair Value Reality Check

You rave about the rosy outlook through 2028/2029, but you’re ignoring the current fair value.

* The **fair value** calculated by InvestingPro based on 12 financial models is a measly €9.84 / $11.67.


* At a current price of ~€14.86 / $15.90, that means a **downside risk of -28.1% to -33.8%**! InvestingPro simply considers the stock **overvalued** at its current level.


#### ❌ 2. Huge GAAP Losses Swept Under the Rug

You’re celebrating the non-GAAP EPS of $0.11. But if you look at the real, unvarnished **GAAP figures**, the facade crumbles dramatically:

* In Q2 2026, there was a **net loss of -$3.6 million (-$0.15 per share)** on a GAAP basis!


* The LTM (last 12 months) operating income is **deep in the red at -$9.7 million**. Legal fees for the Avalanche lawsuit are eating up almost all of the operating income.


#### ❌ 3. Quality Check in the Cellar: “Weak” Rating

In the InvestingPro Quality Check, Everspin is floundering with an overall rating of just **2 out of 5 points (“Weak”)**!

* **Profitability Rating:** A disastrous **1 out of 5 points** (score 1.08).


* **Relative Value:** Also **1 out of 5 points** (score 0.60).


* **Growth:** Only **2 out of 5 points**.



#### ❌ 4. Margin Pressure on the Core Product

While the overall gross margin stood at 53.9% thanks to the government contract, the pure **product gross margin is hovering in the mid- to upper 40% range**. This is due to ongoing cost inflation in packaging and back-end assembly, as well as rising gold prices.

---

### 3. Chart Analysis & Valuation at a Glance 📊

Let’s take a look at the current setup on a weekly basis (52-week range: **€5.08 – €44.65 / $5.86 – $51.50**):

Price (EUR / USD) €22.25 / $25.67 Analyst Consensus Target (Wall Street Bulls)

€14.86 / $15.90 ─── Current Price

€9.84 / $11.67 ─── InvestingPro Fair Value (-33.8% downside risk!)


* **Volatility:** This stock is a real wild card with a 5-year beta of **1.92**. After a massive rally over the past 12 months, the chart is showing clear signs of fatigue in the short term (-8.6% to -13.5% over the last month).


* **Valuation:** With a forward P/E of ~36.4x for 2026 and a P/B of 5.38x, you’re currently paying a hefty premium for a company that’s still posting losses on an unaudited basis.

---

### 4. The Final Verdict for You 🎯

Dear @Tenbagger2024, your technical analysis gets an A+! MRAM is an incredibly exciting market of the future, Everspin is fantastically positioned, and its debt-free balance sheet is a real shield.

But: You’re buying into an extremely volatile small-cap story with **ongoing GAAP losses**, an expensive **patent battle**, and a **fair-value discount of over 30%**.

Anyone getting in here isn’t buying a proven quality stock, but rather a high-risk bet on a breakthrough starting in 2028 (UNISYST). It might pay off—but don’t complain if Raketentoni warned you, should the “fair value magnet” pull the price back down to single digits! 😉

Keep up the great work with your insights—the community benefits from them!

Best regards from Denmark

Yours, Raketentoni
‱
6
‱
profile image
@Raketentoni Thanks, my friend. So for now, I'll keep an eye on it and wait until Jensen Huang sings MRAM's praises.
‱
3
‱
profile image
@Tenbagger2024 I told him that you think he's always mean to you 😬
‱
2
‱
profile image
@Raketentoni I still need him. After all, he's brought a lot of praise with him this time, too. His heart is definitely in it with MRAM.
‱
1
‱